Trial intelligence / Profile preview

DRL-17822 in type II hyperlipidemia

2011-001023-21Phase 2Completed

Sponsor
Dr. Reddy's Laboratories
Start
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of DRL-17822 in Type 2 hyperlipidaemia, sponsored by Dr. Reddy's Laboratories. Started Dec 2011; status: completed.

02

Drugs

DRL-17822
03

Conditions

Type 2 hyperlipidaemia

Beyond the preview

Go deeper on 2011-001023-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001023-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call